| Old Articles: <Older 7691-7700 Newer> |
|---|
 |
The Motley Fool
July 22, 2011 |
Hill-Rom Holdings Earnings Preview Hill-Rom Holdings will unveil its latest earnings on Wednesday.   |
The Motley Fool
July 22, 2011 |
Greatbatch Earnings Preview Medical device maker Greatbatch will unveil its latest earnings on Wednesday, July 27. |
The Motley Fool
July 22, 2011
Brian Orelli |
It's How You Finish That Matters Human Genome Sciences gained approval of the first drug developed for lupus in half a century, but in its first full quarter on the market Benlysta was uninspiring. |
The Motley Fool
July 22, 2011
Brian Orelli |
That's All the Melanoma Market Is Worth? BioSante licenses out its melanoma vaccine for $100,000. |
The Motley Fool
July 22, 2011 |
Teleflex Earnings Preview The medical technology company didn't hit the Street's expectations last quarter, but investors hope that it will rebound this quarter. |
The Motley Fool
July 22, 2011
Matt Koppenheffer |
Could Eli Lilly's Stock Double Your Money? With concerns swirling around the big pharma companies, could it be time to buy Eli Lilly? |
The Motley Fool
July 22, 2011
Luke Timmerman |
Bristol-Myers Acquires Amira Pharmaceuticals, Scoops Up Lung Drug BMY looks to fulfill the need for a lung drug. |
The Motley Fool
July 22, 2011
Anand Chokkavelu |
9 Small Biotechs Near 52-Week Lows Here are nine companies in this space that are within 20% of their 52-week lows and have market caps between roughly $200 million and $500 million. |
The Motley Fool
July 22, 2011
Seth Jayson |
Here's Why Techne's Earnings Are Worse Than They Look With both 12-month and quarterly CCC running worse than average, Techne gets low marks in this cash-conversion checkup. |
The Motley Fool
July 21, 2011 |
LCA-Vision Earnings Preview LCA-Vision will unveil its latest earnings on Tuesday, July 26. |
| <Older 7691-7700 Newer> Return to current articles. |
